Synovus Financial Corp Nuvasive Inc Transaction History

Synovus Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$43.41 - $56.51 $200,901 - $261,528	-4,628 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$47.43 - $60.75 $8,442 - $10,813	178 Added 4.0%	4,628 $224,000
Q2 2020 Aug 10, 2020	BUY	$43.51 - $66.59 $20,058 - $30,697	461 Added 11.56%	4,450 $247,000
Q1 2020 Apr 24, 2020	BUY	$32.82 - $81.13 $10,797 - $26,691	329 Added 8.99%	3,989 $207,000
Q4 2019 Feb 06, 2020	BUY	$60.96 - $77.7 $10,668 - $13,597	175 Added 5.02%	3,660 $280,000
Q3 2019 Nov 01, 2019	BUY	$55.78 - $68.08 $189,484 - $231,267	3,397 Added 3860.23%	3,485 $225,000
Q3 2018 Nov 01, 2018	BUY	$52.03 - $71.41 $4,578 - $6,284	88 New	88 $6,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.